+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
MALE
ID05001477

Registry Study of Customized Transurethral Ultrasound Ablation TULSA-PRO for Prostate Conditions in Adult Men

Led by Profound Medical Inc. · Updated on 2024-11-06

1000

Participants Needed

5

Research Sites

1826 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are collecting data in a patient registry for men undergoing or who have undergone the transurethral ultrasound ablation TULSA procedure as part of their regular medical care. The goal is to better understand real-world safety and effectiveness of TULSA and how it impacts patients quality of life over time. This observational study includes patients with prostate cancer, prostate adenocarcinoma, or benign prostatic hyperplasia. Participants receive the TULSA procedure as part of their routine treatment. The registry gathers baseline information such as demographics, medical history, prostate MRI, biopsy results, PSA levels, and quality of life questionnaires. Follow-up visits occur at 3 months, 6 months, 12 months, 2 to 5 years, and annually thereafter for life. Data includes treatment assessments, complications, PSA, survival, quality of life, and optional financial tracking. During the study, patients complete questionnaires emailed to them at scheduled visits. Data is securely stored and monitored to ensure accuracy. Outcomes measured include complication rates and freedom from treatment failure over 5 years, with lifelong monitoring for survival, quality of life, PSA, and other health indicators. Participation continues until withdrawal or death, providing valuable long-term insights into TULSA treatment effects and patient experience.

CONDITIONS

Brief Title

Customized TULSA-PRO Ablation Registry

Research Team

G

Gina Clarke

A

Arthi Rajamohan

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here